在末期慢性阻塞性肺病中,有或没有严重的肺高血压时,分区特定的重塑模式
Katarina Zeder1, Leigh M Marsh2, Alexander Avian3
1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria; Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
概括
在末期慢性阻塞性肺病 (COPD) 中,严重的肺高血压与肺气和呼吸道炎症的减少有关. 这表明一种独特的COPD表型,其特点是显著的肺血管重塑.
科学领域:
- 肺部医学 肺部医学
- 心血管研究研究心血管研究
- 病理学 病理学 病理学
背景情况:
- 末期慢性阻塞性肺病 (COPD) 与严重的肺高血压 (PH) 往往呈现出不那么严重的呼吸道阻塞.
- 对于COPD患者这种关联的基础组织学依据仍然不清楚.
- 这项研究调查了COPD肺部的肺动脉,呼吸道和肺的结构变化.
研究的目的:
- 量化和比较COPD患者的小肺动脉,小呼吸道和肺气重型的重塑,严重的PH与轻微的PH.
- 探索肺血管改造和COPD中肺气之间的关系.
- 为了区分COPD的组织学特征与不同程度的PH.
主要方法:
- 肺动脉和气道重塑的定量分析,使用专用软件在扩展的肺部.
- 使用平均交叉体距离 (MID) 测量肺气的严重程度.
- 在严重的PH COPD (SevPH-COPD),轻度PH COPD (MildPH-COPD),没有PH COPD (NoPH-COPD),异常性肺动脉高血压 (IPAH) 和健康的供体肺之间进行比较.
主要成果:
- 与MildPH-COPD相比,SevPH-COPD患者表现出更好的强迫生命能力,显著减少肺气 (MID 169微米 vs. 279微米),并减少了呼吸道炎症标志物.
- 在COPD患者中,肺动脉内部和中间加厚与肺动脉平均压力 (mPAP) 密切相关.
- 肺气的严重程度 (MID) 与mPAP负相关,在NoPH-COPD中最高,表明肺气与PH没有直接关联.
结论:
- 末期COPD与严重PH的特点是肺血管的大量重塑.
- 与COPD相比,这些患者的呼吸道炎症和肺气较少,症状轻微或没有PH.
- 这种独特的组织学特征表明,严重PH的COPD可能代表一种独特的表型.
相关概念视频
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Pulmonary Hypertension: Classification and Pathogenesis
180
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
180
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K


